Changes in cytosolic free calcium concentration during myocardial ischemia were measured by "F NMR in 5FBAPTA-loaded perfused rat hearts. The hearts were perfused with Krebs-Henseleit buffer containing 5 fiM of the acetoxy methyl ester of 5FBAPTA, which was hydrolyzed by cytosolic esterases to achieve cytosolic concentrations of 5FBAPTA of 0.12 to 0.65 mM. Cytosolic free calcium concentrations were calculated as the product of the ratio of peak areas for bound and free 5FBAPTA in the NMR spectra and the dissociation constant (708 nM). The basal cytosolic calcium concentration, measured in potassium or magnesium arrested hearts, was 252 nM, and the time-average calcium concentration in beating hearts was 630 nM. Following the onset of total ischemia, there was no immediate substantial change in cytosolic calcium despite a rapid decline in creatine phosphate and ATP and a marked increase in inorganic phosphate as monitored by "P NMR, but by 10 minutes, there was a substantial increase in free calcium concentration. The ratio of peak areas of bound and free 5FBAPTA returned to the preischemic value during reperfusion, and there was no detectable loss of 5FBAPTA from the heart. Creatine phosphate was also restored to its preischemic level during reperfusion. These results indicate that cytosolic free calcium increases during ischemia and is not immediately associated with lethal injury. This increase in cytosolic calcium may activate degradative enzymes that eventually could compromise myocyte viability. (Circulation Research 1987;60:700-707)
N umerous possible mechanisms of lethal myocardial ischemic injury have been proposed, but the precise sequence of events leading to myocyte necrosis has not been resolved. 1 " 3 In particular, it is unclear whether ischemic injury occurs primarily while the tissue is ischemic and is independent of reperfusion or whether reperfusion conditions can influence the eventual fate of ischemic myocytes. Results of experiments with reperfused ischemic isolated hearts indicate that enzyme release and myocyte disruption occur at the onset or within seconds after the onset of reperfusion. 4 These findings would suggest that injury had either occurred prior to reperfusion or else developed extremely rapidly during reperfusion. Evidence for the former is provided by electron microscopic evaluation of unreperfused myocytes, which shows breaks in plasma membranes prior to reperfusion. 4 Evidence for reperfusion injury is provided by studies in which pharmacologic agents such as free radical scavengers have been shown to increase the salvage of ischemic myocytes following temporary coronary artery occlusion and reperfusion. 5 However, these pharmacologic interventions are generally un-able to prevent necrosis entirely, and therefore, it is likely that reperfusion is not the only mechanism of lethal ischemic injury.
One possible mechanism of ischemic injury is calcium overload, 26 " 9 which could occur either while the myocytes are ischemic due to release of calcium from intracellular storage sites and influx of extracellular calcium or immediately on reperfusion due to altered calcium permeability or Na-Ca exchange. Cell death can be induced in cell suspensions by increasing cell calcium with calcium ionophore, 10 but in these experiments, the media provided a virtually infinite reservoir of millimolar extracellular calcium. In contrast, the amount of endogenous calcium in totally ischemic myocardium is small, and there are numerous calcium binding sites that would buffer any increase in intracellular free calcium that might occur. Thus, it is unclear whether intracellular calcium concentration could increase to a significant extent during total ischemia, and there is no direct evidence that intracellular free calcium increases prior to the development of manifestations of lethal injury such as breaks in plasma membranes. It is clear that total cellular calcium increases rapidly during reperfusion after durations of ischemia that are associated with myocyte necrosis." However, even after shorter durations of ischemia followed by reperfusion, it is difficult to distinguish, on the basis of total tissue calcium measurements, between massive mitochondrial calcium accumulation by a few necrotic myocytes and a small increase by the viable myocytes, which constitute the majority of the tissue. Thus, reperfused necrotic myocytes generally contain markedly increased calcium concentration, which probably contributes to myocyte disruption, but the increased calcium is largely a result of lethal injury and does not necessarily indicate that calcium overload caused the injury.
Although numerous investigators have proposed calcium overload as a factor in lethal ischemic injury, 26 " 9 complete evaluation of the precise role of calcium in ischemic myocardial damage requires a method for measuring cytosolic free calcium concentration in ischemic myocytes with intact plasma membranes. If calcium is involved in lethal injury, its concentration must change prior to other manifestations of cell death, such as plasma membrane disruption. In this study, cytosolic free calcium was measured in ischemic myocardium using "F NMR and the calcium indicator 5FBAPTA. 12 The indicator is infused as the acetoxymethyl ester that diffuses into the myocytes and is hydrolyzed by cytosolic esterases. The free acid is retained by the myocytes and forms a 1:1 complex with calcium, which has an apparent dissociation constant of approximately 700 nM. The ratio of Ca-5FBAPTA to free 5FBAPTA is a measure of cytosolic free calcium. The results indicate that a reversible increase in cytosolic free calcium occurs between 10 and 15 minutes of total ischemia.
Materials and Methods
Adult male Sprague-Dawley rats (Charles River Suppliers, Wilmington, Mass.) weighing between 250 and 400 g were anesthetized with pentobarbital. The heart was excised and the aorta cannulated within 15 seconds. Retrograde perfusion was instituted from a reservoir 80 cm above the aortic cannula. The perfusate was Krebs-Henseleit buffer containing (in mM) NaCl 120, KC1 4.7, MgSO 4 1.2, KH 2 PO 4 1.2, CaCl 2 1.25, NaHCO 3 25 , and glucose 5. The buffer was continuously aerated with humidified 95% Oj-5% CO 2 and was maintained at 37° C. After 15 minutes of control nonrecirculating perfusion, loading with the acetoxymethyl ester of 5FBAPTA (5FBAPTA-AM) (Molecular Probes, Junction City, Oreg.) was begun. BAPTA, one of the calcium indicators synthesized by Tsien, 13 was originally fluorine labelled by Smith et al 12 to make it a useful NMR indicator. Hearts were perfused with 300-1,000 ml of 5 /xM 5FBAPTA-AM at a perfusion pressure of 80 cm water. During loading, there was a decrease in the force of contraction. After the predetermined amount of 5FBAPTA-AM had been circulated through the heart, perfusion was resumed with the standard Krebs-Henseleit buffer, and the heart was placed in a standard 20-mm NMR tube. The apex of the heart was generally about 1 cm from the bottom of the tube. A drain line was placed inside the tube and extended to the bottom. The drain line was connected to a variable-speed Masterflex peristaltic pump (Cole-Parmer, Chicago, 111.), which evacuated the coronary effluent before it could accumulate on the bottom of the tube. Thus, the hearts were not bathed during the experiment. Although immersion of perfused organs generally enhances the ability to obtain a homogeneous magnetic field, leading to improved sensitivity, this method could complicate the interpretation of the fluorine NMR spectra since any FB APT A released by myocytes would be retained in the bathing solution. The difficulties associated with correcting for extracellular FBAPTA are discussed elsewhere.
14 The use of the unbathed organ in the present studies has compromised optimal magnetic field homogeneity but has eliminated the possibility of accumulation of extracellular FBAPTA in the NMR coil volume.
Experiments were performed using a 20-mm 19 F probe (Doty Scientific, Columbia, S.C.) or a broad band 20-mm Nicolet probe, with the decoupler coil tuned to 339.7 MHz to measure I9 F and the observe coil tuned to 31 P, thus allowing measurement of both 19 F and 31 P. These experiments were performed on a Nicolet 360 NMR spectrometer (General Electric, Fremont, Calif.) with a vertical bore magnet and a variable temperature probe set at 37° C. The sample was shimmed on H 2 O and a (nonspinning) line width at half height of ~0.25 ppm was routinely obtained. A 40°p ulse angle, a 500-/isec delay, and a 127-msec acquisition time were used for the 19 F studies. For 3I P measurements, a 40° pulse angle, a 2-second postacquisition delay, and a 205-msec acquisition time were used.
For assessment of contractile function, a rubber balloon on the tip of a polyethylene catheter was inserted through the left atrium into the left ventricle. The catheter was connected to a Statham P23d pressure transducer (Gould Inc., Oxnard, Calif.) that was outside the magnet at the same height as the heart. The balloon was inflated to give an end-diastolic pressure of 5-15 cm water. In some experiments, the hearts were arrested by increasing perfusate potassium concentration to 25 mM or by increasing perfusate magnesium concentration to 15 mM. In other experiments, the hearts were made totally ischemic by occluding the aortic cannula inflow line. The temperature of the hearts inside the magnet was maintained at 37° C. After 15 minutes of total ischemia, the hearts were reperfused by reopening the aortic cannula inflow line. At the end of the experiment, the heart was removed from the magnet and frozen in liquid nitrogen for analysis of the amount of 5FBAPTA loading.
To determine the amount of 5FBAPTA loading, hearts were dried to constant weight and homogenized with a Polytron (Brinkman Instruments, Westbury, N. Y.) in 150 mM KC1 buffered with Tris-MOPS to pH 7.10. The concentration of FBAPTA in the extract was compared with the concentration of a 6-fluorotryptophan standard, taking into account the differences in Tl and the number of fluorines per molecule. To assess the regional distribution of FBAPTA, a lyophilized heart was dissected, and the right ventricular free wall, interventricular septum, left ventricular free wall subdivided into endocardial and epicardial halves, and atria were homogenized separately. The results showed a relatively uniform distribution of FBAPTA in the ventricular myocardium but much less loading in the atria. The poor loading of the atria could be due to the inclusion of connective tissue with the atrial sample. Nevertheless, the vast majority of the FBAPTA accumulated in the heart was in the left ventricular myocardium due to the much greater mass of the left ventricular free wall and septum as compared with the right ventricular free wall. The observation of homogeneous loading of FBAPTA has been previously reported by Metcalfe et al.
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Results
The use of 5FBAPTA to measure cytosolic free calcium in an intact heart preparation is demonstrated in Figure 1 . Panel A shows a representative "F NMR spectrum consisting of 5,000 scans. The concentrations of free 5FBAPTA and Ca-5FBAPTA are proportional to their peak areas. The cytosolic free calcium concentration can be calculated from the ratio of the peak area of calcium complexed indicator (B) to the peak area of the free indicator (F) according to the following equation:
where K D is the dissociation constant of Ca-5FBAPTA, which has been determined to be 708 nM. 15 The dissociation constant is relatively independent of changes in free Mg 2+ concentration and pH; since Mg 2+ and pH variations affect the shift difference between Ca-FBAPTA and free FBAPTA, there is a constant monitor of such changes. This calculation assumes that all of the accumulated 5FBAPTA is located in the cytosol. A study of isolated myocytes with the calcium indicator fura 2 has shown that some dye can accumulate in the sarcoplasmic reticulum and nucleus but that this results in only a slight (<10%) overestimation of cytosolic free calcium concentration. 16 The degree of dye loading into intracellular organelles in the present study was likely to be less than that reported by Williams et al 16 because the duration of dye loading was shorter in the present study.
The time-averaged cytosolic free calcium concentration in Figure 1A is 700 nM. The mean value obtained from 10 hearts is 630 ± 97 nM (mean ± SEM). The time-averaged calcium concentration reflects the calcium concentration during systole as well as diastole and the proportion of the cycle spent in systole and diastole. To obtain an estimate of the true diastolic calcium concentration, hearts were arrested with either 25 mM KC1 or 15 mM MgCl 2 . The arrest resulted in a marked reduction in the cytosolic calcium concentration to a value of 248 ± 34 nM (mean ± SEM, n = 4) for potassium arrest ( Figure IB) or 261 ±22 nM (mean ± SEM, n = 3) for magnesium arrest. This value is in agreement with other measures of resting cytosolic free calcium concentration in cardiac muscle 17 " 19 and confirms the conclusion that 5FBAPTA loading does not damage the myocytes since the ability to maintain low cytosolic calcium levels is a sensitive measure of cellular integrity. There is no need to correct the data for extracellular 5FBAPTA because the hearts were continuously perfused and the effluent was evacuated immediately. Thus, any indicator that might be released would be rapidly washed out. Furthermore, there was no evidence of leakage since the peak areas of free and bound 5FBAPTA in the heart remained essentially constant for several hours. The levels of 5FBAPTA loading in later experiments were varied, but these variations had no significant effect on the time-averaged cytosolic free calcium. The range of loading was varied from 0.3 to 1.6 pimol/g dry weight, which converts to an intracellular concentration of 0.12 to 0.65 mM, using the conversion factor of 2.5 ml of intracellular water per gram dry weight for the perfused rat heart. 20 Thus, the presence of up to 0.65 mM calcium chelator in the sarcoplasm of the myocytes did not affect the time-averaged cytosolic free calcium concentration.
Although FBAPTA loading did not affect mean cytosolic free calcium levels, it did alter the kinetics of calcium release and sequestration, as detected by changes in left ventricular pressure development and dP/dt. As shown in Figure 2 , FBAPTA loading markedly depressed pressure development, positive dP/dt Ca FBAPTA FBAPTA FIGURE 1. I9 F NMR spectra of 5FBAPTA-loaded perfused rat heart. The heart was loaded with 5FBAPTA as described in "Materials and Methods. " Spectra were obtained on a beating heart, spectrum A, and in the same heart after the beating was arrested with the addition of 25 mM KCl, spectrum B. during contraction, and negative dP/dt during relaxation. After loading with approximately 300 ml of 5 /xM 5FBAPTA-AM, peak systolic pressure was 65% of control, maximum dP/dt was 60% of control, and minimum dP/dt was 55% of control. At the end of loading (1,000 ml), the FBAPTA content of the heart in Figure 2 was 1.1 /nmol/g dry weight (0.44 mM).
The pressure recordings showed that the left ventricle continued to contract at nearly the same rate as at the start of loading, but all aspects of the contraction cycle were markedly damped. Time-to-peak tension was more than doubled, and the rate of relaxation was depressed. Thus, although the peak systolic free cytosolic calcium concentration was presumably reduced by FBAPTA loading, the time-averaged calcium concentration was unaffected because there was a corresponding increase in the systolic interval and a decrease in the duration of diastole. Additional evidence that 5FBAPTA loading is not toxic to cardiac myocytes was obtained by 3I P NMR before and after loading. A slight ( < 10%) reduction in the creatine phosphate resonance was observed after loading, but there was no detectable change in ATP content (data not shown). The change in creatine phosphate may not be a manifestation of injury, but rather a reflection of the prolonged systolic interval and the shortened duration of diastole.
The effect of total ischemia on sarcoplasmic calcium was investigated initially using low levels of 5FBAPTA loading, which were associated with less impairment of contractile function than with high loading. Figure 3 shows combined I9 F spectra of 2 hearts with 5FBAPTA loading of approximately 0.2 mM. The signal-to-noise ratio is poor with low loading. This 
F NMR spectra of globally ischemic hearts with low loading of 5FBAPTA. These spectra show the addition of spectra from 2 hearts lightly loaded with 5FBAPTA (5FBAPTA loading ~0.2mM). Preischemic spectrum (A) was accumulated for a total of 10,000 scans. Ischemic spectrum (B) was obtained between 11 and 15 minutes of ischemia and contained 4,000 accumulations. After 15 minutes of ischemia, reflow was begun, and recovery spectrum (C) was accumulated between 10 and 30 minutes after reflow was started.
did not interfere significantly with the determination of preischemic and recovery sarcoplasmic calcium concentration because the preischemic and recovery spectra could be accumulated over a longer period of time. However, it did limit the time resolution for measurement of calcium changes during ischemia. The preischemic spectrum, collected over a period of 22 minutes in each heart, showed nearly equal amounts of Ca-FBAPTA and free FBAPTA. In the ischemic spectrum obtained between 11 and 15 minutes of ischemia, virtually all of the 5FBAPTA was in the Ca-5FBAPTA peak, and no measurable free 5FBAPTA peak was observed. The signal-to-noise ratio in this combined spectrum was 3.7, and therefore, a free 5FBAPTA peak less than 1/3.7 times the Ca-5FBAPTA peak would not be distinguishable above the noise. More precise quantitation was not possible with low 5FBAPTA loading. After 15 minutes of global ischemia, the heart was reperfused, and the ratio of Ca-5FBAPTA to free 5FBAPTA, as well as the absolute peak areas, returned to preischemic levels. These data demonstrate that cytosolic free calcium increased to greater than or equal to 2.7 yiM. during 11-15 minutes of total ischemia, that the 5FBAPTA remained intracellular during ischemia and therefore could not be washed out during reperfusion, and that the increase in cytosolic calcium during brief periods of ischemia was reversible on reoxygenation.
To improve the quantitation of the calcium rise during ischemia, higher levels of 5FBAPTA loading were used. As shown in Figure 4 , the signal-to-noise ratio was markedly improved with a 5FBAPTA loading of 0.65 mM, permitting more rapid data acquisition. The preischemic spectrum (Figure 4A ), acquired in 11 minutes, was virtually identical to the preischemic spectrum in Figure 3, cytosolic free calcium concentration was unaffected by the amount of 5FBAPTA loading, which is consistent with data reported using quin2, indicating that basal calcium levels are not altered over a large range of chelator loading. 21 Following acquisition of control I9 F scans, the aortic inflow line was clamped, and spectra were accumulated during the ischemic interval. The 0-6 minute spectrum ( Figure 4B ) showed no discernible difference from control. Changes began to become apparent after 6 minutes, and the 9-15 minute spectrum showed a marked shift in the relative proportions of bound and free 5FBAPTA ( Figure 4C ). Calculation of cytosolic free calcium from the bound and free peak areas in Figure 4C yielded a value of 3.3 /xM. Including data from other experiments with similar levels of 5FBAPTA loading, the cytosolic free calcium was 3.0 ± 0.3 fiM after 9-15 minutes of total ischemia, a significant increase over the preischemic value of 0.61 ± 0.06 AIM(/?< 0.01). After 15 minutes of ischemia, the heart was reperfused with oxygenated KrebsHenseleit buffer, resulting in a return to control ratios of bound to free indicator without significant net loss of indicator. Thus, the rise in Ca-FBAPTA in Figure  4C is not because of leakage of the indicator into the extracellular space where it would be washed out during reperfusion but rather reflects the rise in sarcoplasmic calcium during ischemia, which is reversible during reperfusion.
To characterize further the extent of injury sustained during 15 minutes of total ischemia, 3I P spectra of 5FBAPTA loaded hearts were obtained prior to ischemia, during ischemia, and during reperfusion. Figure 5 shows combined 31 P spectra of 2 hearts with 5FBAPTA loading of approximately 0.4 mM. The preischemic spectrum ( Figure 5A ) showed approximately equal amounts of creatine phosphate and ATP, which is typical of 5FBAPTA loaded hearts. The inorganic phosphate peak included extracellular phosphate in the perfusate. The spectrum obtained from 0 to 7.5 minutes of ischemia ( Figure 5B ) showed a marked reduction in creatine phosphate and a much smaller decrease in ATP measured by the y3-phosphate resonance of ATP. Between 7.5 and 15 minutes of ischemia ( Figure 5C ), there was no detectable creatine phosphate or ATP, but there was a massive inorganic phosphate peak that was progressively shifted upfield, indicating tissue acidosis. Reperfusion resulted in full recovery of creatine phosphate but only partial restoration of tissue ATP, as shown in Figure 5D . These are the expected changes in high energy phosphate levels during reperfusion following brief, nonlethal durations of ischemia. 22 ATP does not recover fully because adenine nucleotides are degraded during ischemia to nucleosides and bases, which are washed out during reperfusion. 23 Changes in pressure development and resting tension during ischemia were assessed by placing a balloon in the left ventricle of hearts with and without prior 5FBAPTA loading. In the absence of 5FBAPTA, peak systolic pressure rapidly declined during global ischemia, while end-diastolic pressure remained es-sentially constant. After 2 minutes of ischemia, there was no detectable contractile activity. Resting tension remained low for 7-8 minutes and then increased markedly and remained elevated for the remainder of the ischemic interval. Rhythmic contractile activity was not immediately reestablished on reperfusion, but after several minutes, beating resumed. Peak systolic pressure did not recover fully to the preischemic level. A similar sequence of events was observed in the 5FBAPTA-loaded hearts except that there was an initial decline in resting tension at the onset of ischemia in Pj PC ATP FIGURE 5.
3I
P NMR spectra of a globally ischemic 5FBAPTA loaded perfused heart. These spectra show the addition from 2 hearts. Spectrum A shows the addition of 2 hearts, both accumulated for 7 minutes (total NA = 400) before ischemia was started. Spectrum B was acquired during early ischemia (time 0-7.5 minutes, NA = 400). Spectrum C was acquired during late ischemia (7.5-15 hearts with moderate to high loading. Pressure development in 5FBAPTA-loaded hearts was lower than in control hearts prior to ischemia, but the cessation of pressure development occurred 1-2 minutes after the onset of total ischemia, i.e., with the same time course as in the absence of FBAPTA. Heart rate did not change from control during the initial 1-2 minutes of ischemia. Resting tension began to rise within 5 minutes after the onset of ischemia, more rapidly than in the absence of FBAPTA.
Discussion
Numerous investigators have suggested that calcium overload may be involved in lethal ischemic myocardial injury, but there has been no conclusive evidence that cytosolic free calcium concentration increased in the ischemic myocytes prior to the onset of lethal injury. 3 The recent development of an NMR technique for measuring cytosolic free calcium in intact tissues with the calcium indicator 5FBAPTA 12 has permitted a direct evaluation of the possible role of increased cytosolic calcium in the evolution of ischemic necrosis. Loading of myocytes with 5FBAPTA to the levels used in the present study and in a previous study altered contractility.' 5 The duration of systole was increased, peak pressure development was reduced, and the duration of diastole was decreased; these changes were the expected effects of a high-affinity, high-capacity calcium buffer in the sarcoplasm of the myocytes. That hydrolysis of 5FBAPTA-AM was not toxic under these experimental conditions was evident from the lack of effect of loading on tissue ATP, the low cytosolic free calcium concentration in arrested hearts, and the stability of function at the completion of loading. In addition, Metcalfe et al" showed that there was no contractility change following loading with a pH indicator as the acetoxymethyl ester to the same final concentration as 5FBAPTA. Finally, there was no significant difference in the time-average control calcium concentration in hearts with less than 0.3 mM FBAPTA vs. the hearts with greater than 0.5 mM FBAPTA. Similar findings were reported with quin2-loaded cells. 21 Thus, although 5FBAPTA alters cardiac function, it does not appear to damage the myocytes. The ability of the "F NMR technique to measure cytosolic free calcium in intact tissues represents a substantial advantage over optical techniques such as aequorin 24 or quin2 13 for examination of calcium redistribution during ischemia. Ischemia can only be studied in intact tissues with relatively small extracellular volumes, while the optical techniques are most suitable for studies with isolated single cells, cultured cells, or the most superficial layers of intact tissues. However, the most superficial layers of intact tissues may not be susceptible to ischemic injury because of diffusion of oxygen from the environment. Thus, the NMR technique is the best approach for assessment of in situ ischemia-induced changes in the center of an ischemic region.
Previous studies have shown that there is little change in calcium homeostasis immediately following the onset of anoxia or metabolic inhibition in mammalian papillary muscle and in isolated ventricular myocytes from adult rat heart or embryonic chick heart. 14 ' 25 ' 26 Cytosolic free calcium ultimately increased under these conditions, 142627 but the reversibility and the relevance to ischemic injury were uncertain. Ischemia is different from anoxia or metabolic inhibition in several respects. One distinguishing fea-' ture is the essentially infinite extracellular calcium reservoir that is a characteristic of anoxia but not of ischemia, where the extracellular volume is small. If influx of extracellular calcium is necessary for the rise in cytosolic free calcium during anoxia or metabolic inhibition, the magnitude of the influx could be much greater when the extracellular volume is greater. Notwithstanding this potentially differentiating feature of ischemia, the present data are in agreement with the previous studies: there is no immediate change in timeaverage cytosolic free calcium during early ischemia, but there is a delayed increase. Despite the lack of an immediate change in time-average cytosolic calcium, there could be an early increase in diastolic free calcium, paralleling the rise in resting tension, if there were a corresponding decrease in systolic calcium. Nevertheless, the present data suggest that calcium concentration remains in the control range during the initial 5-6 minutes of ischemia and exceeds the control range after 9-10 minutes of ischemia. Most important, the present study shows that the increase in cytosolic free calcium precedes the loss of plasma membrane structural integrity and is fully reversible on reperfusion. Evidence that the plasma membrane is structurally intact in these experiments is the retention of 5FBAPTA in the ischemic-reperfused myocytes as well as the complete restoration of creatine phosphate during reperfusion. Lethally injured myocytes lose creatine and therefore cannot resynthesize creatine phosphate, 28 and it is unlikely that necrotic myocytes would be able to retain 5FBAPTA. In addition, the heart resumes beating during reperfusion. Ion fluxes can increase during reperfusion after 30 minutes of ischemia, 29 but if calcium permeability is increased during reperfusion after 15 minutes of ischemia, the increase does not result in a significant rise in cytosolic free calcium during reperfusion as compared with control.
The magnitude of the increase in cytosolic free calcium concentration appeared to be small but could have been underestimated in these experiments since these calcium chelators (FBAPTA, quin2) are known to buffer calcium transients. 13 - 30 The effect of 5FBAPTA concentration on the rates of pressure development and relaxation is an indication of its buffering capacity. Endogenous calcium binding sites would also be expected to suppress the rise in cytosolic calcium during ischemia, but there appear to be many more relatively low-affinity binding sites (Km>10 /xM) than there are higher-affinity sites (10 /u.M>Km>l /iM). 31 The present data demonstrate that cytosolic free calcium increases early during ischemia to a value that is at least 3 ^iM. This represents a substantial increase above the physiologic range but would be much less than the extracellular concentration. Elevated cytosolic free calcium can be tolerated, at least briefly, by the myocytes, and calcium homeostasis is rapidly reestablished during reperfusion. This finding demonstrates that cytosolic calcium can increase during ischemia without requiring or causing any plasma membrane structural alteration that would be manifest during the reperfusion period. Plasma membrane integrity is demonstrated by the essentially complete retention of 5FBAPTA during reperfusion as well as the restoration of creatine phosphate content. These observations emphasize the potential for a calcium-dependent degradative mechanism to be activated while myocytes are ischemic and to be activated prior to any change in plasma membrane integrity that would permit unrestricted entry of extracellular calcium into the cytosolic compartment during reperfusion. Thus, reperfusion is not required for the initiation of calcium-induced injury. The relation between increased cytosolic calcium and lethal injury is unclear, but previous studies have shown that conditions that raise platelet calcium concentrations to approximately 3 /AM 32 result in proteolysis of cytoskeletal proteins because of activation of a /JLM calcium-dependent protease. 33 A similar fiM calcium-dependent protease is present in cardiac muscle and is capable of degrading cytoskeletal proteins. 34 Plasma membrane integrity is dependent on an intact cytoskeleton, and therefore cytoskeletal proteolysis could be the proximate cause of plasma membrane disruption during ischemia.
In summary, the present study establishes the value of I9 F NMR and 5FBAPTA for evaluation of calcium redistribution during ischemia in an intact heart preparation. The data provide a direct demonstration that cytosolic free calcium increases during ischemia, after an initial lag, but prior to loss of plasma membrane integrity. The magnitude of the increase is at least 3 /u.M and may be greater. This level of calcium overload could activate calcium-dependent degradative processes.
